The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues including medicines regulation, UK and EU trading relationships, access to talent, and the future of UK science.
We are creating a new relationship with the European Union that secures patient access to medicines and protects public health.
A voluntary agreement between the Government and the pharmaceutical industry.
We work with the government, industry, medical charities and organisations and trade associations to support the pharmaceutical and life sciences sector.
Celebrating the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future
28 January 2018
Making sure patients continue to get the medicines they need is of upmost importance as we negotiate the UK’s withdrawal from the EU.
25 January 2018
The ABPI is delighted to announce the appointment of Professor Carole Longson MBE as Chief Scientific Officer at the Association of the British Pharmaceutical Industry (ABPI). Carole joins the ABPI from her current role as Executive Director and Board Member at the National Institute for Health and Care Excellence (NICE).